CEACAM5 and rectal cancer: This study demonstrated that dynamic changes in inflammatory and tumor markers, specifically neutrophil-to-lymphocyte ratio (NLR) and carcinoembryonic antigen (CEA), have significant prognostic value in patients with locally advanced rectal cancer (LARC) undergoing neoadjuvant chemoradiotherapy (CRT) followed by surgery.